The Supreme Court has rejected a request to review a $70 million Risperdal ruling against Johnson & Johnson over male breast growth side effects, meaning the verdict will stand.
A Pennsylvania judge upheld a massive Risperdal verdict, but reduced the original punitive damages from $8 billion to $6.8 million.
Johnson & Johnson faces more than 100,000 lawsuits over problems with its products, which may cost up to $50 billion to settle.
A Philadelphia jury has ordered Johnson & Johnson to pay $8 billion in punitive damages to a man who developed breasts as a child due to the side effects of…
The Pennsylvania Supreme Court will hear an appeal that could determine when the statute of limitations for thousands of Risperdal breast growth lawsuits.
A ruling by a panel of Pennsylvania judges opens the way for about 6,000 plaintiffs with Risperdal lawsuits filed in that state to seek punitive damages from Johnson & Johnson…
The Pennsylvania Superior Court has overturned Johnson & Johnson's only win before a jury in Risperdal litigation in that state, ordering a new trial.
A Risperdal lawsuit has resulted in a $1 million verdict for a 24-year-old man who began growing breasts after he started taking the drug when he was 9-years-old.
New Risperdal lawsuits are being filed at a prodigious rate, with the number of cases more than doubling this year in Pennsylvania state court.
Teva Pharmaceuticals is recalling several hundred bottles of generic Invega due to problems with the extended-release tablets dissolving properly, which could lead to underdosing.
